Arax Advisory Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.95M Buy
49,085
+46,825
+2,072% +$2.19M 0.02% 665
2026
Q1
$81.6K Sell
2,260
-404
-15% -$16.9K ﹤0.01% 1483
2025
Q4
$125K Sell
2,664
-1,579
-37% -$66.7K ﹤0.01% 1235
2025
Q3
$138K Buy
4,243
+1,317
+45% +$46.9K ﹤0.01% 1403
2025
Q2
$121K Buy
2,926
+600
+26% +$23.2K 0.01% 847
2025
Q1
$97.1K Buy
2,326
+753
+48% +$39.2K 0.01% 729
2024
Q4
$92.2K Sell
1,573
-874
-36% -$51.7K 0.01% 699
2024
Q3
$169K Buy
2,447
+270
+12% +$17.4K 0.02% 381
2024
Q2
$139K Buy
+2,177
New +$164K 0.01% 404

Other funds holding BRKR

Arax Advisory Partners's BRKR Position: Q2 2026 in Review

Arax Advisory Partners increased its Bruker (BRKR) stake by 2,072% in Q2 2026, buying an estimated $2.19M and bringing the position to 49,085 shares worth $2.95M. The position accounts for 0.02% of the portfolio, ranked #665.

Arax Advisory Partners first reported a position in BRKR in Q2 2024 and has held it in 9 quarters since. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Arax Advisory Partners held 49,085 shares of Bruker worth $2.95M as of Q2 2026.
  • Arax Advisory Partners bought 46,825 Bruker shares in Q2 2026, an estimated $2.19M.
  • Bruker made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #665 holding.
  • Arax Advisory Partners first reported a position in Bruker in Q2 2024 and has held it in 9 quarters since.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.